Efficacy News and Research

RSS

RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

With this approval, RINVOQ® is the first and only Janus Kinase inhibitor approved to treat patients across the spectrum of axial spondyloarthritis (nr-axSpA and ankylosing spondylitis) in the EU.

From AbbVie 29 Jul 2022

Tannins as therapeutic agents against SARS-CoV-2

Researchers reviewed tannins as therapeutic agents against SARS-CoV-2.

29 Jul 2022

Moderna COVID vaccine is more effective in older and sicker veterans over time

Researchers report the higher effectiveness of the Moderna COVID-19 vaccine as compared to the Pfizer COVID-19 vaccine.

28 Jul 2022

Researchers discover cell signaling pathway responsible for the development of esophageal cancers

Of the roughly 20,000 people in the U.S. diagnosed with esophageal cancer this year, just 4,000 are likely to still be alive in 2027.

28 Jul 2022

AI-based gaze deviation detection can aid in quick stroke diagnosis, expand access to lifesaving care

A new study presented today at the Society of NeuroInterventional Surgery's (SNIS) 19th Annual Meeting shows that artificial intelligence (AI) technology can identify when a patient is having a stroke caused by emergent large vessel occlusion (LVO), therefore making them a candidate for endovascular therapy (EVT).

28 Jul 2022

The global mutation landscape of the SARS-CoV-2 non-structural protein 1

Researchers describe the evolution of the SARS-CoV-2 non-structural protein 1 (NSP1).

28 Jul 2022

New bacteria-killing copper coating could reduce infections from high-touch surfaces

A new copper coating that kills bacteria quicker and in greater amounts than current formulations could soon be available for hospitals and other high-traffic facilities.

28 Jul 2022

TMPRSS2 protein, a novel target for SARS-CoV-2 drugs

A new study reports the activity of a compound which inhibited TMPRSS2, ultimately preventing severe COVID-19.

28 Jul 2022

Transplant remains the standard of care for liver cancer patients, regardless of age

Physicians and researchers from UK HealthCare's Transplant Center and the University of Kentucky Markey Cancer Center conducted a study of patients over the age of 70 with a type of liver cancer called hepatocellular carcinoma (HCC) and how the outcomes of ablative treatments compare to liver transplants.

28 Jul 2022

Study shows efficacy and safety of cytisine as a smoking cessation therapy

Research published in the Journal of Thoracic Oncology shows cytisine may be a safe and effective smoking cessation therapy in lung cancer screening volunteers.

28 Jul 2022

Oncology trial data not available for independent scrutiny, study finds

Despite a commitment from the pharmaceutical industry in 2014 to improve data transparency, more than half of the clinical trials that led to the United States Food and Drug Administration approving anticancer medicines over the past 10 years are not available for independent scrutiny, a multi-national study led by Flinders University has found.

28 Jul 2022

Comparing SARS-CoV-2 Omicron BA.2 and BA.5 vaccine breakthrough infections

In a new study, investigators explored the SARS-CoV-2 Omicron BA.2 and BA.5 vaccine breakthrough infection likelihood.

28 Jul 2022

The effect of Artemisia annua hot water extracts against the SARS-CoV-2 Omicron variant

Researchers assessed the effect of Artemisia annua hot water extracts against the SARS-CoV-2 Omicron variant.

28 Jul 2022

The effects of CBD in the treatment of COVID-19–related inflammatory symptoms

Researchers reviewed the effectiveness of cannabidiol in treating COVID-19 inflammatory-related symptoms.

28 Jul 2022

Phage therapeutics can be used to fight multidrug-resistant pathogens

Scientists with the Texas A&M College of Agriculture and Life Sciences were among those providing the biochemical tools needed to help save a man's life through a unique emergency intervention in 2016.

27 Jul 2022

Study finds molnupiravir well-tolerated, and effective in vaccinated and unvaccinated

Researchers report the phase II efficacy and safety of molnupiravir in both unvaccinated and vaccinated individuals.

27 Jul 2022

Efficacy of COVID mRNA vaccines among patients on CAR‐T‐lymphocyte therapy

Researchers evaluate the effectiveness of mRNA COVID-19 vaccines among patients receiving CAR‐T‐lymphocyte therapy.

27 Jul 2022

Efficacy of monoclonal antibodies against Omicron BA.1, BA.2, and BA.5

Researchers evaluate the neutralizing potency of therapeutic monoclonal antibodies against three sub-lineages of the SARS-CoV-2 Omicron variant.

27 Jul 2022

Study reveals why service dogs may improve mental health for some veterans with PTSD

A new analysis dives into the use of service dogs by U.S. veterans who have posttraumatic stress disorder (PTSD), illuminating factors and mechanisms that may underlie the mental health effects of these relationships.

27 Jul 2022

New technology converts discarded bullfrog skin into wound healing products

A new clinical-grade collagen made from discarded bullfrog skin is leapfrogging from the lab bench to clinics soon.

27 Jul 2022

Efficacy News and Research

RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

Tannins as therapeutic agents against SARS-CoV-2

Moderna COVID vaccine is more effective in older and sicker veterans over time

Researchers discover cell signaling pathway responsible for the development of esophageal cancers

AI-based gaze deviation detection can aid in quick stroke diagnosis, expand access to lifesaving care

The global mutation landscape of the SARS-CoV-2 non-structural protein 1

New bacteria-killing copper coating could reduce infections from high-touch surfaces

TMPRSS2 protein, a novel target for SARS-CoV-2 drugs

Transplant remains the standard of care for liver cancer patients, regardless of age

Study shows efficacy and safety of cytisine as a smoking cessation therapy

Oncology trial data not available for independent scrutiny, study finds

Comparing SARS-CoV-2 Omicron BA.2 and BA.5 vaccine breakthrough infections

The effect of Artemisia annua hot water extracts against the SARS-CoV-2 Omicron variant

The effects of CBD in the treatment of COVID-19–related inflammatory symptoms

Phage therapeutics can be used to fight multidrug-resistant pathogens

Study finds molnupiravir well-tolerated, and effective in vaccinated and unvaccinated

Efficacy of COVID mRNA vaccines among patients on CAR‐T‐lymphocyte therapy

Efficacy of monoclonal antibodies against Omicron BA.1, BA.2, and BA.5

Study reveals why service dogs may improve mental health for some veterans with PTSD

New technology converts discarded bullfrog skin into wound healing products

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News